Mauro Bernardi
#128,353
Most Influential Person Now
Researcher
Mauro Bernardi's AcademicInfluence.com Rankings
Mauro Bernardicomputer-science Degrees
Computer Science
#5514
World Rank
#5824
Historical Rank
Algorithms
#188
World Rank
#191
Historical Rank
Computational Linguistics
#787
World Rank
#800
Historical Rank
Machine Learning
#1499
World Rank
#1521
Historical Rank
Download Badge
Computer Science
Mauro Bernardi's Degrees
- PhD Computer Science University of Milan
- Masters Computer Science University of Milan
- Bachelors Computer Science University of Milan
Similar Degrees You Can Earn
Why Is Mauro Bernardi Influential?
(Suggest an Edit or Addition)Mauro Bernardi's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Acute-on-chronic liver failure is a distinct syndrome that develops in patients with acute decompensation of cirrhosis. (2013) (2069)
- Peripheral arterial vasodilation hypothesis: A proposal for the initiation of renal sodium and water retention in cirrhosis (1988) (1523)
- EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis. (2018) (1347)
- The management of ascites in cirrhosis: Report on the consensus conference of the international Ascites club (2003) (826)
- Bacterial infections in cirrhosis: a position statement based on the EASL Special Conference 2013. (2014) (723)
- Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites. (2015) (672)
- Serum alpha-fetoprotein for diagnosis of hepatocellular carcinoma in patients with chronic liver disease: influence of HBsAg and anti-HCV status. (2001) (664)
- Development and validation of a prognostic score to predict mortality in patients with acute-on-chronic liver failure. (2014) (617)
- Baclofen efficacy in reducing alcohol craving and intake: a preliminary double-blind randomized controlled study. (2002) (474)
- Clinical Course of acute‐on‐chronic liver failure syndrome and effects on prognosis (2015) (455)
- EASL Clinical Practical Guidelines on the management of acute (fulminant) liver failure. (2017) (455)
- Systemic inflammation in decompensated cirrhosis: Characterization and role in acute‐on‐chronic liver failure (2016) (455)
- Mechanisms of decompensation and organ failure in cirrhosis: From peripheral arterial vasodilation to systemic inflammation hypothesis. (2015) (398)
- Sepsis in cirrhosis: report on the 7th meeting of the International Ascites Club (2005) (379)
- Q‐T interval prolongation in cirrhosis: Prevalence, relationship with severity, and etiology of the disease and possible pathogenetic factors (1998) (367)
- Semiannual and annual surveillance of cirrhotic patients for hepatocellular carcinoma: effects on cancer stage and patient survival (Italian experience) (2002) (324)
- Interactions of the heart and the liver. (2013) (319)
- Albumin: Pathophysiologic basis of its role in the treatment of cirrhosis and its complications (2013) (316)
- Albumin infusion in patients undergoing large‐volume paracentesis: A meta‐analysis of randomized trials (2012) (287)
- Hyponatremia in cirrhosis: From pathogenesis to treatment (1998) (282)
- Long-term albumin administration in decompensated cirrhosis (ANSWER): an open-label randomised trial (2018) (272)
- Semiannual surveillance is superior to annual surveillance for the detection of early hepatocellular carcinoma and patient survival. (2010) (262)
- Terlipressin plus albumin versus midodrine and octreotide plus albumin in the treatment of hepatorenal syndrome: A randomized trial (2015) (253)
- The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure. (2015) (251)
- Characteristics, risk factors, and mortality of cirrhotic patients hospitalized for hepatic encephalopathy with and without acute-on-chronic liver failure (ACLF). (2014) (248)
- AISF position paper on nonalcoholic fatty liver disease (NAFLD): Updates and future directions. (2017) (243)
- Diagnostic and Prognostic Role of α-Fetoprotein in Hepatocellular Carcinoma: Both or Neither? (2006) (241)
- Diagnosis and management of acute kidney injury in patients with cirrhosis: revised consensus recommendations of the International Club of Ascites (2015) (223)
- Bone mass and metabolism in patients with celiac disease. (1995) (222)
- Differential boosting of innate and adaptive antiviral responses during pegylated-interferon-alpha therapy of chronic hepatitis B. (2013) (205)
- Diagnostic and prognostic role of alpha-fetoprotein in hepatocellular carcinoma: both or neither? (2006) (201)
- Review article: alcoholic liver disease – pathophysiological aspects and risk factors (2006) (186)
- Characterisation of a stereotypical cellular and extracellular adult liver progenitor cell niche in rodents and diseased human liver (2010) (174)
- Refractory ascites: pathogenesis, definition and therapy of a severe complication in patients with cirrhosis (2010) (169)
- Hepatocellular carcinoma in non-cirrhotic liver: a reappraisal. (2010) (166)
- Mitochondrial oxidative injury and energy metabolism alteration in rat fatty liver: Effect of the nutritional status (2001) (166)
- Cardiac electrophysiological abnormalities in patients with cirrhosis. (2006) (158)
- Posttransplantation lymphoproliferative disorders. (2003) (157)
- The relationship of dehydroepiandrosterone sulfate (DHEAS) to endocrine-metabolic parameters and functional status in the oldest-old. Results from an Italian study on healthy free-living over-ninety-year-olds. (1996) (153)
- Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF. (2019) (152)
- Treatments for hepatocellular carcinoma in elderly patients are as effective as in younger patients: a 20-year multicentre experience (2010) (152)
- Recent advances in the natural history of hepatocellular carcinoma. (2008) (150)
- Influence of pattern of clinical presentation and of gluten-free diet on bone mass and metabolism in adult coeliac disease. (1996) (147)
- The PREDICT study uncovers three clinical courses in acutely decompensated cirrhosis with distinct pathophysiology (120/120). (2020) (146)
- The MELD score in patients awaiting liver transplant: strengths and weaknesses. (2011) (141)
- Reduced cardiovascular responsiveness to exercise-induced sympathoadrenergic stimulation in patients with cirrhosis. (1991) (138)
- An open multicentric study evaluating 4-hydroxybutyric acid sodium salt in the medium-term treatment of 179 alcohol dependent subjects. GHB Study Group. (1996) (138)
- Alcohol use disorders in the elderly: A brief overview from epidemiology to treatment options (2012) (136)
- Rapid suppression of alcohol withdrawal syndrome by baclofen. (2002) (133)
- Celiac disease and alopecia areata: report of a new association. (1995) (133)
- Surveillance for Hepatocellular Carcinoma in Elderly Italian Patients With Cirrhosis: Effects on Cancer Staging and Patient Survival (2004) (130)
- Albumin in decompensated cirrhosis: new concepts and perspectives (2020) (130)
- Effects of Albumin Treatment on Systemic and Portal Hemodynamics and Systemic Inflammation in Patients With Decompensated Cirrhosis. (2019) (129)
- The hepatic apelin system: A new therapeutic target for liver disease (2008) (125)
- Clinical indications for the albumin use: still a controversial issue. (2013) (120)
- Natural history of cirrhotic patients with small esophageal varices: a prospective study (2000) (120)
- Posttranscriptional changes of serum albumin: Clinical and prognostic significance in hospitalized patients with cirrhosis (2014) (119)
- Prevalence of Monoclonal Gammopathies in Patients with Hepatitis C Virus Infection (1998) (118)
- Satavaptan for the management of ascites in cirrhosis: efficacy and safety across the spectrum of ascites severity (2011) (118)
- Starvation impairs antioxidant defense in fatty livers of rats fed a choline-deficient diet. (2000) (116)
- The Systemic Inflammation Hypothesis: Towards a New Paradigm of Acute Decompensation and Multiorgan Failure in Cirrhosis. (2020) (114)
- Surveillance for Early Diagnosis of Hepatocellular Carcinoma: Is It Effective in Intermediate/Advanced Cirrhosis? (2007) (113)
- A novel model of CCl4-induced cirrhosis with ascites in the mouse. (2009) (112)
- Estimation of lead-time bias and its impact on the outcome of surveillance for the early diagnosis of hepatocellular carcinoma. (2014) (107)
- High incidence of allograft dysfunction in liver transplanted patients treated with pegylated-interferon alpha-2b and ribavirin for hepatitis C recurrence: possible de novo autoimmune hepatitis? (2006) (106)
- Role of human albumin in the management of complications of liver cirrhosis. (2014) (105)
- Gross pathologic types of hepatocellular carcinoma in Italian patients: Relationship with demographic, environmental, and clinical factors (1993) (103)
- Neutrophil gelatinase-associated lipocalin is a biomarker of acute-on-chronic liver failure and prognosis in cirrhosis. (2016) (103)
- Association Between Grade of Acute on Chronic Liver Failure and Response to Terlipressin and Albumin in Patients With Hepatorenal Syndrome (2018) (103)
- Plasma Norepinephrine, Weak Neurotransmitters, and Renin Activity During Active Tilting in Liver Cirrhosis: Relationship with Cardiovascular Homeostasis and Renal Function (2007) (102)
- Yttrium‐90 radioembolization vs sorafenib for intermediate‐locally advanced hepatocellular carcinoma: a cohort study with propensity score analysis (2015) (100)
- PREDICT identifies precipitating events associated with the clinical course of acutely decompensated cirrhosis. (2020) (98)
- Epidemiology and outcomes of bloodstream infection in patients with cirrhosis. (2014) (98)
- Addressing Profiles of Systemic Inflammation Across the Different Clinical Phenotypes of Acutely Decompensated Cirrhosis (2019) (98)
- Efficacy and safety of the stepped care medical treatment of ascites in liver cirrhosis: a randomized controlled clinical trial comparing two diets with different sodium content. (2008) (98)
- Assessment of Sepsis-3 criteria and quick SOFA in patients with cirrhosis and bacterial infections (2017) (94)
- Renal sodium retention during upright posture in preascitic cirrhosis. (1993) (94)
- Incidence of hepatitis C virus infection in Italian patients with idiopathic pulmonary fibrosis. (1996) (93)
- Aldosterone related blood volume expansion in cirrhosis before and during the early phase of ascites formation. (1983) (93)
- Mobilization of Bone Marrow‐Derived Hematopoietic and Endothelial Stem Cells After Orthotopic Liver Transplantation and Liver Resection (2006) (93)
- Impact of interferon therapy on the natural history of hepatitis C virus related cirrhosis (2001) (93)
- The changing scenario of hepatocellular carcinoma over the last two decades in Italy. (2012) (92)
- Acute kidney injury and acute-on-chronic liver failure classifications in prognosis assessment of patients with acute decompensation of cirrhosis (2014) (91)
- QT interval prolongation in liver cirrhosis: innocent bystander or serious threat? (2012) (91)
- Autonomic dysfunction and hyperdynamic circulation in cirrhosis with ascites (1999) (90)
- Hepatitis B virus-related hepatocarcinogenesis: molecular oncogenic potential of clear or occult infections. (2010) (87)
- QT interval in patients with non-cirrhotic portal hypertension and in cirrhotic patients treated with transjugular intrahepatic porto-systemic shunt. (2003) (87)
- The reduced tolerance of rat fatty liver to ischemia reperfusion is associated with mitochondrial oxidative injury. (2005) (86)
- Effect of the Etiology of Viral Cirrhosis on the Survival of Patients with Hepatocellular Carcinoma (2006) (86)
- Hyperdynamic circulation of advanced cirrhosis: a re-appraisal based on posture-induced changes in hemodynamics. (1995) (84)
- Effect of chronic beta-blockade on QT interval in patients with liver cirrhosis. (2008) (83)
- Effects of a selective vasopressin V2 receptor antagonist, satavaptan, on ascites recurrence after paracentesis in patients with cirrhosis. (2010) (82)
- Patients with advanced hepatocellular carcinoma need a personalized management: A lesson from clinical practice (2018) (82)
- The hemodynamic status of preascitic cirrhosis: An evaluation under steady‐state conditions and after postural change (1992) (82)
- Liver Transplantation from Donors Aged 80 Years and Over: Pushing the Limit (2004) (81)
- Corrigendum to "EASL Clinical Practice Guidelines for the management of patients with decompensated cirrhosis" [J Hepatol 69 (2018) 406-460]. (2018) (77)
- Cytokine profile of peripheral blood mononuclear cells from patients with different outcomes of hepatitis C virus infection (2005) (77)
- QT Interval Correction in Patients with Cirrhosis (2007) (77)
- Ischemia‐reperfusion injury in rat fatty liver: Role of nutritional status (1999) (76)
- Gamma-hydroxybutyric acid versus naltrexone in maintaining alcohol abstinence: an open randomized comparative study. (2003) (76)
- Current limits and future challenges in the management of renal dysfunction in patients with cirrhosis: report from the International Club of Ascites (2013) (74)
- Circulating and hepatic endocannabinoids and endocannabinoid‐related molecules in patients with cirrhosis (2009) (74)
- Hepatorenal disorders: role of the renin-angiotensin-aldosterone system. (1994) (71)
- The evolutionary scenario of hepatocellular carcinoma in Italy: an update (2017) (71)
- A prospective multicentre study of the epidemiology and outcomes of bloodstream infection in cirrhotic patients. (2017) (70)
- Human albumin in the management of complications of liver cirrhosis (2012) (69)
- High risk of hepatocellular carcinoma in anti‐HBe positive liver cirrhosis patients developing lamivudine resistance (2004) (69)
- Vitamin E as treatment for chronic hepatitis B: results of a randomized controlled pilot trial. (2001) (68)
- Gamma Hydroxybutyric Acid (GHB) for the Treatment of Alcohol Dependence: A Review (2009) (68)
- A case of gamma-hydroxybutyric acid withdrawal syndrome during alcohol addiction treatment: utility of diazepam administration. (1999) (67)
- Lamivudine treatment for acute hepatitis B after liver transplantation. (1998) (66)
- Pathophysiology of ascites and functional renal failure in cirrhosis. (1988) (64)
- Plasma cystatin C is a predictor of renal dysfunction, acute‐on‐chronic liver failure, and mortality in patients with acutely decompensated liver cirrhosis (2017) (64)
- Food deprivation exacerbates mitochondrial oxidative stress in rat liver exposed to ischemia-reperfusion injury. (2001) (62)
- Orchestration of Tryptophan‐Kynurenine Pathway, Acute Decompensation, and Acute‐on‐Chronic Liver Failure in Cirrhosis (2019) (62)
- Impairment of mitochondrial oxidative phosphorylation in rat fatty liver exposed to preservation-reperfusion injury. (2004) (62)
- Alcohol and viral hepatitis: a mini-review. (2009) (61)
- Six score systems to evaluate candidates with advanced cirrhosis for orthotopic liver transplant: Which is the winner? (2010) (61)
- A new approach to the use of α-fetoprotein as surveillance test for hepatocellular carcinoma in patients with cirrhosis (2014) (60)
- Safety of two different doses of simvastatin plus rifaximin in decompensated cirrhosis (LIVERHOPE-SAFETY): a randomised, double-blind, placebo-controlled, phase 2 trial. (2019) (60)
- A randomized controlled study comparing elemental diet and steroid treatment in Crohn's disease (1997) (60)
- Pathophysiology of decompensated cirrhosis: Portal hypertension, circulatory dysfunction, inflammation, metabolism and mitochondrial dysfunction. (2021) (60)
- Liver transplantation from hepatitis B surface antigen positive donors: a safe way to expand the donor pool. (2012) (59)
- Stem cell mobilization and collection in patients with liver cirrhosis (2008) (58)
- Renal function impairment induced by change in posture in patients with cirrhosis and ascites. (1985) (58)
- Plasma endothelin-1 and -3 in cirrhosis: relationship with systemic hemodynamics, renal function and neurohumoral systems. (1996) (55)
- Early Increase of Bone Resorption in Patients with Liver Cirrhosis Secondary to Viral Hepatitis (2000) (55)
- Impact of Etiology of Cirrhosis on the Survival of Patients Diagnosed With Hepatocellular Carcinoma During Surveillance (2007) (55)
- Etiologic factors and clinical presentation of hepatocellular carcinoma: Differences between cirrhotic and noncirrhotic Italian patients (1995) (55)
- The impact of infection by multidrug‐resistant agents in patients with cirrhosis. A multicenter prospective study (2017) (55)
- Bed-rest-induced hypernatriuresis in cirrhotic patients without ascites: does it contribute to maintain 'compensation'? (1992) (54)
- Novel perspectives in the management of decompensated cirrhosis (2018) (54)
- Alcohol use in adults. (2013) (53)
- Liver transplantation from donors aged 80 years and over: pushing the limit. (2004) (52)
- Prevalence and severity of dementia among northern Italian centenarians (1999) (52)
- Reversal of liver fibrosis by the antagonism of endocannabinoid CB1 receptor in a rat model of CCl4-induced advanced cirrhosis (2012) (52)
- Reduced prevalence of ischemic events and abnormal supraortic flow patterns in patients with liver cirrhosis (2005) (52)
- Comparing and combining gamma-hydroxybutyric acid (GHB) and naltrexone in maintaining abstinence from alcohol: An open randomised comparative study (2007) (52)
- Importance of plasma aldosterone concentration on the natriuretic effect of spironolactone in patients with liver cirrhosis and ascites. (1985) (51)
- QT interval prolongation by acute gastrointestinal bleeding in patients with cirrhosis (2012) (50)
- Comparison between alcohol‐ and hepatitis C virus‐related hepatocellular carcinoma: clinical presentation, treatment and outcome (2016) (50)
- Chronobiological evaluation of sympathoadrenergic function in cirrhosis. Relationship with arterial pressure and heart rate. (1987) (50)
- Clinical, pathological, and antibody pattern of latent celiac disease: report of three adult cases. (1996) (50)
- Medications acting on the GABA system in the treatment of alcoholic patients. (2010) (50)
- Cannabinoid type 1 receptor antagonism delays ascites formation in rats with cirrhosis. (2009) (49)
- Pegylated interferon plus ribavirin for recurrent Hepatitis C infection after liver transplantation in naïve and non-responder patients on a stable immunosuppressive regimen. (2006) (49)
- Prognostic value of the galactose test in predicting survival of patients with cirrhosis evaluated for liver transplantation. A prospective multicenter Italian study. AISF Group for the Study of Liver Transplantation. Associazione Italiana per lo Studio del Fegato. (1996) (47)
- Adaptive response in hepatitis B virus infection (2014) (47)
- 6 EXTRACORPOREAL LIVER SUPPORT BY FRACTIONATED PLASMA SEPARATION AND ADSORPTION (PROMETHEUS) IN PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE (HELIOS STUDY): A PROSPECTIVE RANDOMIZED CONTROLLED MULTICENTER STUDY (2010) (46)
- Circadian variation in renal sodium and potassium handling in cirrhosis. The role of aldosterone, cortisol, sympathoadrenergic tone, and intratubular factors. (1989) (46)
- Chemiluminescent real time imaging of post-ischemic oxygen free radicals formation in livers isolated from young and old rats. (1998) (46)
- Interaction of alcohol intake and cofactors on the risk of cirrhosis (2009) (45)
- Proteins but not nucleic acids are molecular targets for the free radical attack during reoxygenation of rat hepatocytes. (1997) (44)
- In vitro effect of thymosin‐α1 and interferon‐α on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C (2001) (44)
- Curative therapies are superior to standard of care (transarterial chemoembolization) for intermediate stage hepatocellular carcinoma (2017) (44)
- Anti-HBs re-seroconversion after liver transplantation in a patient with past HBV infection receiving a HBsAg positive graft. (2009) (44)
- Rat hepatocytes isolated from alcohol‐induced fatty liver have an increased sensitivity to anoxic injury (1997) (44)
- Role of Contrast‐Enhanced Ultrasonography in Primary Hepatic Lymphoma (2010) (42)
- Hyponatremia influences the outcome of patients with acute-on-chronic liver failure: an analysis of the CANONIC study (2014) (42)
- Stem cells for end stage liver disease: how far have we got? (2008) (41)
- Interferon-α plus ribavirin in chronic hepatitis C resistant to previous interferon-α course : results of a randomized multicenter trial (1999) (41)
- Impaired tuftsin activity in cirrhosis: relationship with splenic function and clinical outcome (2002) (40)
- The role of the endocannabinoid system in liver diseases. (2009) (39)
- Incidence of craving for and abuse of gamma-hydroxybutyric acid (GHB) in different populations of treated alcoholics: an open comparative study (2009) (39)
- Short-term methadone administration reduces alcohol consumption in non-alcoholic heroin addicts. (2002) (39)
- Clinical trial: peg‐interferon alfa‐2b and ribavirin for the treatment of genotype‐1 hepatitis C recurrence after liver transplantation (2008) (39)
- Serum Pancreatic Enzyme Concentrations in Chronic Viral Liver Diseases (1999) (38)
- Transverse myelitis following hepatitis B vaccination. (1993) (37)
- Combined mechanical and pharmacologic thrombolysis for portal vein thrombosis in liver-graft recipients and in candidates for liver transplantation. (2004) (37)
- Alpha-1-thymosin and transcatheter arterial chemoembolization in hepatocellular carcinoma patients: a preliminary experience. (1998) (37)
- Transcatheter arterial chemoembolization therapy for patients with hepatocellular carcinoma: a case-controlled study. (2005) (36)
- Efficacy of lamivudine therapy for advanced liver disease in patients with precore mutant hepatitis B virus infection awaiting liver transplantation1 (2002) (36)
- Spontaneous bacterial peritonitis: from pathophysiology to prevention (2010) (36)
- The concept of therapeutic hierarchy for patients with hepatocellular carcinoma: A multicenter cohort study (2017) (36)
- Impairment of blood pressure control in patients with liver cirrhosis during tilting: study on adrenergic and renin-angiotensin systems. (1982) (36)
- Digestive and Liver Disease (2011) (35)
- Virus-Specific Immune Response in HBeAg-Negative Chronic Hepatitis B: Relationship with Clinical Profile and HBsAg Serum Levels (2013) (35)
- A double-blind, placebo-controlled, pilot trial of thymosin alpha 1 for the treatment of chronic hepatitis C. (2008) (35)
- Effective albumin concentration and cirrhosis mortality: from concept to reality. (2013) (34)
- Plasma amino acid patterns in experimental acute hepatic failure: comparison between hepatectomy and liver devascularization in pigs. (1981) (34)
- Bone marrow derived stem cells for the treatment of end-stage liver disease. (2014) (33)
- Systemic and regional hemodynamics in pre-ascitic cirrhosis. (1997) (33)
- Chronobiological study of factors affecting plasma aldosterone concentration in cirrhosis. (1986) (33)
- Adaptation of subcellular glutathione detoxification system to stress conditions in choline-deficient diet induced rat fatty liver (2003) (32)
- Polymorphisms in the IL‐1 gene cluster influence systemic inflammation in patients at risk for acute‐on‐chronic liver failure (2017) (32)
- Quantitative evaluation of liver function by the methionine and aminopyrine breath tests in the early stages of liver transplantation (2003) (32)
- Anthropometric characteristics of healthy Italian nonagenarians and centenarians (1997) (31)
- Pharmacological management of alcohol dependence: From mono-therapy to pharmacogenetics and beyond (2014) (31)
- Monoclonal gammopathy in patients with chronic hepatitis C virus infection. (1996) (31)
- Metronomic capecitabine as second-line treatment for hepatocellular carcinoma after sorafenib discontinuation (2018) (31)
- The HEART score with high-sensitive troponin T at presentation: ruling out patients with chest pain in the emergency room (2017) (30)
- Real-time contrast-enhanced ultrasound--a new simple tool for detection of peritoneal-pleural communications in hepatic hydrothorax. (2008) (30)
- Oxidative injury in rat fatty liver exposed to ischemia-reperfusion is modulated by nutritional status. (2005) (30)
- Utility of Tumor Burden Score to Stratify Prognosis of Patients with Hepatocellular Cancer: Results of 4759 Cases from ITA.LI.CA Study Group (2018) (30)
- Hyponatremia in Patients with Cirrhosis of the Liver (2014) (30)
- AISF-SIMTI Position Paper: The appropriate use of albumin in patients with liver cirrhosis. (2016) (29)
- Hemodynamic and renal effects of ascites apheresis, concentration and reinfusion in advanced cirrhosis. (1995) (29)
- Lymphocytotoxicity test against rabbit hepatocytes in chronic liver diseases. (1978) (29)
- Long-term treatment of hepatorenal syndrome as a bridge to liver transplantation. (2011) (29)
- TOWARDS A NEW DEFINITION OF DECOMPENSATED CIRRHOSIS. (2021) (29)
- How albumin administration for cirrhosis impacts on hospital albumin consumption and expenditure. (2011) (29)
- Prevention of reoxygenation injury by sodium salicylate in isolated-perfused rat liver. (1998) (29)
- Mass spectrometric characterization of human serum albumin dimer: A new potential biomarker in chronic liver diseases. (2015) (27)
- Diagnosis and Treatment of Alcohol Use Disorder in Patients With End‐Stage Alcoholic Liver Disease (2019) (26)
- Liver transplantation for patients with alcoholic liver disease: an open question. (2011) (26)
- Serum hepatitis B surface antigen monitoring in long‐term lamivudine‐treated hepatitis B virus patients (2011) (26)
- Sudden unexpected fatal encephalopathy in adults with OTC gene mutations-Clues for early diagnosis and timely treatment (2014) (26)
- Doxorubicin coupled to lactosaminated albumin: Effects on rats with liver fibrosis and cirrhosis. (2006) (26)
- Monoclonal gammopathy in patients with chronic hepatitis C virus infection [letter] (1996) (26)
- Years of life that could be saved from prevention of hepatocellular carcinoma (2016) (25)
- Evidence of oxidative imbalance in long-term liver transplant patients. (2002) (25)
- Autonomic neuropathy in advanced liver disease (1996) (25)
- Reinfusion of highly purified CD133+ bone marrow-derived stem/progenitor cells in patients with end-stage liver disease: A phase I clinical trial. (2015) (24)
- The Endocannabinoid System and Liver Diseases (2008) (24)
- In vitro effect of thymosin-alpha1 and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C. (2001) (24)
- A Fast and Validated Mass Spectrometry Method for the Evaluation of Human Serum Albumin Structural Modifications in the Clinical Field (2013) (24)
- Ischaemia‐modified albumin: a marker of bacterial infection in hospitalized patients with cirrhosis (2015) (24)
- Transient elastography in healthy subjects and factors influencing liver stiffness in non-alcoholic fatty liver disease: An Italian community-based population study. (2016) (24)
- Sodium oxybate in maintaining alcohol abstinence in alcoholic patients with and without psychiatric comorbidity (2011) (24)
- Restaging Patients With Hepatocellular Carcinoma Before Additional Treatment Decisions: A Multicenter Cohort Study (2018) (23)
- Assessing the role of amino acids in systemic inflammation and organ failure in patients with ACLF. (2020) (22)
- Daily profile of plasma endothelin-1 and -3 in pre-ascitic cirrhosis: relationships with the arterial pressure and renal function. (1997) (22)
- On-treatment serum albumin level can guide long-term treatment in patients with cirrhosis and uncomplicated ascites. (2020) (22)
- Does the evidence support a survival benefit of albumin infusion in patients with cirrhosis undergoing large-volume paracentesis? (2016) (22)
- Determination of Effective Albumin in Patients With Decompensated Cirrhosis: Clinical and Prognostic Implications (2021) (22)
- C-11 Acetate Does Not Enhance Usefulness of F-18 FDG PET/CT in Differentiating Between Focal Nodular Hyperplasia and Hepatic Adenoma (2009) (22)
- Intermittent anoxia reduces oxygen free radicals formation during reoxygenation in rat hepatocytes. (1997) (22)
- Colitis associated to chemotherapy with 5-fluorouracil. (1997) (22)
- Thymosin‐α 1 plus interferon‐α for naive patients with chronic hepatitis C: results of a randomized controlled pilot trial (2004) (21)
- Albumin Homodimers in Patients with Cirrhosis: Clinical and Prognostic Relevance of a Novel Identified Structural Alteration of the Molecule (2016) (21)
- A Brief Up-Date of the Use of Sodium Oxybate for the Treatment of Alcohol Use Disorder (2016) (21)
- Human herpesvirus‐8‐related Kaposi's sarcoma after liver transplantation successfully treated with cidofovir and liposomal daunorubicin (2005) (21)
- Prevalence of and risk factors for fatty liver in the general population of Northern Italy: the Bagnacavallo Study (2018) (21)
- Optimum use of diuretics in managing ascites in patients with cirrhosis (2009) (21)
- De novo hepatocellular carcinoma of liver allograft: a neglected issue. (2015) (20)
- A novel stop codon mutation within the hepatitis B surface gene is detected in the liver but not in the peripheral blood mononuclear cells of HIV‐infected individuals with occult HBV infection (2013) (20)
- Ageing affects anoxia/reoxygenation injury in rat hepatocytes. (1998) (20)
- Patterns of HCV-RNA and HCV core antigen in the early monitoring of standard treatment for chronic hepatitis C. (2013) (20)
- Orthotopic liver transplantation for alcoholic liver disease: rates of survival, complications and relapse. (1997) (20)
- Sonographic appearance of pseudomembranous colitis. (1985) (20)
- Ascites apheresis, concentration and reinfusion for the treatment of massive or refractory ascites in cirrhosis. (1994) (20)
- Albumin infusion may decrease the incidence and severity of overt hepatic encephalopathy in liver cirrhosis (2019) (20)
- Portal vein arterialization: a new surgical option against acute liver failure? (2005) (20)
- Pharmacological approaches to the management of alcohol addiction. (2002) (19)
- Relationship between hepatic haemodynamics assessed by Doppler ultrasound and liver stiffness. (2012) (19)
- Variable activation of phosphoinositide 3-kinase influences the response of liver grafts to ischemic preconditioning. (2009) (19)
- Chronic hepatitis B: Are we close to a cure? (2015) (19)
- High plasma levels of atrial natriuretic peptide in preascitic cirrhosis: Indirect evidence of reduced natriuretic effectiveness of the peptide (1995) (19)
- Clinical practice guidelines for the management of cirrhotic patients with ascites. Committee on Ascites of the Italian Association for the Study of the Liver. (1999) (19)
- Terlipressin infusion induces ischemia of breast skin in a cirrothic patient with hepatorenal syndrome. (2008) (19)
- Prevalence of wild-type in NS5A-PKR protein kinase binding domain in HCV-related hepatocellular carcinoma. (2002) (19)
- In vitro effect of thymosin‐alpha1 and interferon‐alpha on Th1 and Th2 cytokine synthesis in patients with eAg‐negative chronic hepatitis B (2008) (18)
- Soluble CD30 serum level in HCV-positive chronic active hepatitis: A surrogate marker of disease activity? (2000) (18)
- Two yr mycophenolate mofetil plus low‐dose calcineurin inhibitor for renal dysfunction after liver transplant (2009) (18)
- Long Term Follow-up and Outcome of Liver Transplantation for Alcoholic Liver Disease: A Single Center Case-control Study (2010) (18)
- Effect of ethanol on adenosine triphosphate, cytosolic free calcium, and cell injury in rat hepatocytes (1996) (18)
- Interferon-alpha plus ribavirin and amantadine in patients with post-transplant hepatitis C: results of a pilot study. (2001) (18)
- A new prognostic model to predict dropout from the waiting list in cirrhotic candidates for liver transplantation with MELD score <18 (2015) (17)
- Interferon alpha plus ketoprofen or interferon alpha plus ribavirin in chronic hepatitis C non-responder to interferon alpha alone: results of a pilot study. (1999) (17)
- Systemic and regional hemodynamics in pre-ascitic cirrhosis: effects of posture. (2003) (17)
- 102 EFFECTS OF SATAVAPTAN, AN ORAL VASOPRESSIN V2 RECEPTOR ANTAGONIST, ON MANAGEMENT OF ASCITES AND MORBIDITY IN LIVER CIRRHOSIS IN A LONG-TERM, PLACEBO-CONTROLLED STUDY (2009) (17)
- Sodium oxybate in maintaining alcohol abstinence in alcoholic patients according to Lesch typologies: A pilot study (2014) (17)
- Virological analysis, genotypes and mutational patterns of the HBV precore/core gene in HBV/HCV‐related hepatocellular carcinoma (2006) (17)
- Study on coagulation profile of patients with cirrhosis of the liver undergoing elective fibreoptic injection sclerotherapy of oesophageal varices. (1984) (17)
- A randomized controlled trial of thymosin-alpha1 versus interferon alfa treatment in patients with hepatitis B e antigen antibody--and hepatitis B virus DNA--positive chronic hepatitis B. (1996) (17)
- 1404 DIAGNOSIS, PREVALENCE, AND PROGNOSIS OF ACUTE-ON- CHRONIC LIVER FAILURE (ACLF): RESULTS OF THE EASL-CHRONIC LIVER FAILURE (CLIF) CONSORTIUM CANONIC STUDY (2012) (16)
- The rational use of albumin in patients with cirrhosis and ascites. A Delphi study for the attainment of a consensus on prescribing standards. (2004) (16)
- Extended infusion of β-lactams for bloodstream infection in patients with liver cirrhosis: an observational multicenter study. (2019) (16)
- Disturbances of acid–base balance in cirrhosis: a neglected issue warranting further insights (2005) (16)
- Hepatitis C in the elderly: a multicentre cross-sectional study by the Italian Association for the Study of the Liver. (2012) (16)
- An Innovative Hyperbaric Hypothermic Machine Perfusion Protects the Liver from Experimental Preservation Injury (2012) (16)
- Long-term albumin administration improves survival in patients with decompensated cirrhosis: final results of the “ANSWER” study (2017) (15)
- A novel sodium overload test predicting ascites decompensation in rats with CCl4-induced cirrhosis. (2005) (15)
- Gamma hydroxybutyrric acid (GHB) withdrawal does not occur at therapeutic dosage. (2005) (15)
- Unaltered dopaminergic modulation of aldosterone secretion in cirrhosis. (1988) (15)
- Evolution of hepatitis C virus non‐structural 5A gene in the progression of liver disease to hepatocellular carcinoma (2007) (15)
- Hepatitis C Virus‐related chronic liver disease in elderly patients: an Italian cross‐sectional study (2010) (15)
- International Ascites Club Sepsis in cirrhosis: report on the 7th meeting of the (2006) (15)
- Hepatitis C virus infection and lymphoproliferative disorders. (1995) (14)
- Approach and management of dysnatremias in cirrhosis (2018) (14)
- Effects of granulocyte colony stimulating-factor in a rat model of acute liver injury. (2007) (14)
- Novel strategies to treat alcohol dependence with sodium oxybate according to clinical practice. (2015) (14)
- Generation of free radicals during anoxia and reoxygenation in perfused osteoblastlike cells. (1997) (14)
- Renal function and effective beta-blockade in cirrhosis with ascites. Relationship with baseline sympathoadrenergic tone. (1989) (14)
- Portal hypertension and liver cirrhosis in rats: effect of the β3‐adrenoceptor agonist SR58611A (2012) (14)
- Portal vein arterialization for the treatment of post resection acute liver failure in the rat. (2006) (13)
- Effect of potassium canrenoate, an anti-aldosterone agent, on incidence of ascites and variceal progression in cirrhosis. (2006) (13)
- Pattern of comorbidities and 1-year mortality in elderly patients with COPD hospitalized in internal medicine wards: data from the RePoSI Registry (2020) (13)
- Interferon-alpha plus ribavirin in chronic hepatitis C resistant to previous interferon-alpha course: results of a randomized multicenter trial. (1999) (13)
- Alcohol misuse and traffic accidents (2007) (13)
- Transthoracic electrical bioimpedance: a non-invasive technique for the evaluation of the haemodynamic alterations in patients with liver cirrhosis. (2005) (13)
- Art in the hospital: its impact on the feelings and emotional state of patients admitted to an internal medicine unit. (2010) (13)
- Renal sodium retention in preascitic cirrhosis: Expanding knowledge, enduring uncertainties (2002) (13)
- Thymalfasin: clinical pharmacology and antiviral applications. (1998) (13)
- Chemoembolization versus chemotherapy in elderly patients with unresectable hepatocellular carcinoma and contrast uptake as prognostic factor. (1997) (13)
- Experimental observations and clinical implications of fasting and diet supplementation in fatty livers. (2003) (12)
- "Torsade de pointes" during amiodarone infusion in a cirrhotic woman with a prolonged QT interval. (2009) (12)
- P476 SHORT-TERM (28-DAY) CLINICAL COURSE AND TRANSPLANT-FREE MORTALITY IN ACUTE ON CHRONIC LIVER FAILURE (ACLF); EVIDENCE FOR REVERSIBILITY OF ACLF (A STUDY FROM THE CANONIC DATABASE) (2014) (12)
- Vitamin E for Chronic Hepatitis B (1998) (12)
- Mitochondrial oxidative injury in rat fatty livers exposed to warm ischemia-reperfusion. (2000) (12)
- Individualizing duration of antibiotic therapy in community-acquired pneumonia. (2017) (12)
- Effect of Ischemia-Reperfusion on Heat Shock Protein 70 and 90 Gene Expression in Rat Liver: Relation to Nutritional Status (1998) (12)
- The Renin‐Angiotensin‐Aldosterone System in Cirrhosis (2007) (12)
- Serum potassium circadian rhythm. Relationship with aldosterone. (1985) (12)
- Accesses for alcohol intoxication to the emergency department and the risk of re-hospitalization: An observational retrospective study. (2018) (11)
- Successful treatment of CCl4-induced acute liver failure with portal vein arterialization in the rat. (2003) (11)
- Albumin Administration is Efficacious in the Management of Patients with Cirrhosis: A Systematic Review of the Literature (2020) (11)
- Effect of Helicobacter pylori infection, age and epithelial cell turnover in a general population at high risk for gastric cancer. (1999) (11)
- Development and Validation of a Scoring System That Includes Corrected QT Interval for Risk Analysis of Patients With Cirrhosis and Gastrointestinal Bleeding. (2019) (11)
- Eosinophilic gastroenteritis in a patient with large-cell anaplastic lung carcinoma: a paraneoplastic syndrome? (1994) (11)
- Faculty Opinions recommendation of Cirrhosis and SARS-CoV-2 infection in US Veterans: risk of infection, hospitalization, ventilation and mortality. (2020) (11)
- γ-hydroxybutyrate as a treatment for alcoholism (2005) (11)
- The role and indications of albumin in advanced liver disease. (2019) (11)
- Interferon‐α combined with ketoprofen as treatment of naïve patients with chronic hepatitis C: a randomized controlled trial (2003) (10)
- The use of human albumin in patients with cirrhosis: a European survey (2018) (10)
- ENDPOINTS AND DESIGN OF CLINICAL TRIALS IN PATIENTS WITH DECOMPENSATED CIRRHOSIS: POSITION PAPER OF THE LIVERHOPE CONSORTIUM. (2020) (10)
- Hepatocellular carcinoma appearance in patients with hepatitis C virus‐related chronic liver disease 90 and 70 months after sustained virological response to interferon and ribavirin (2007) (10)
- Prediction of nosocomial acute-on-chronic liver failure in patients with cirrhosis admitted to hospital with acute decompensation (2019) (10)
- Long‐term albumin administration in patients with decompensated cirrhosis. It is time for a reappraisal (2019) (10)
- In vitro effect of indomethacin and interferon-alpha on Th1 and Th2 cytokine synthesis in patients with chronic hepatitis C. (2004) (10)
- Gender influences cold preservation-reoxygenation injury in the liver. (1999) (10)
- Suppression of craving for gamma-hydroxybutyric acid by naltrexone administration: three case reports. (2005) (10)
- Baclofen in the treatment of alcohol withdrawal syndrome: A randomized comparative study versus diazepam (2006) (10)
- Acquired intestinal lymphangiectasia successfully treated with a low-fat and medium-chain triacylglycerol-enriched diet in a patient with liver transplantation. (2006) (10)
- Posttransplant lymphoproliferative disorders in liver transplanted patients: a report of four cases. (2006) (10)
- Vitamin E for the treatment of E‐antigen‐positive chronic hepatitis B in paediatric patients: results of a randomized phase 2 controlled study (2017) (9)
- Immunological studies of the jejunal mucosa in normal subjects and adult celiac patients. (1974) (9)
- Terlipressin infusion induces Tako-Tsubo syndrome in a cirrhotic man with hepato-renal syndrome (2011) (9)
- Pro: The Role of Albumin in Pre–Liver Transplant Management (2019) (9)
- Imbalance of Neutrophils and Lymphocyte Counts Can Be Predictive of Hepatocellular Carcinoma Occurrence in Hepatitis C-related Cirrhosis Treated With Direct-acting Antivirals. (2018) (9)
- Effects of a new loop diuretic (muzolimine) in cirrhosis with ascites: Comparison with furosemide (1986) (9)
- Low replication and variability of HBV pre-core in concomitant infection with hepatitis B and hepatitis C viruses (2007) (9)
- Mutations in the E2–PePHD region of hepatitis C virus type 1b in patients with hepatocellular carcinoma (2005) (9)
- Muscle circulation contributes to hyperdynamic circulatory syndrome in advanced cirrhosis. (2008) (9)
- Comparative pharmacodynamics of furosemide and muzolimine in cirrhosis. Study on renal sodium and potassium handling and renin-aldosterone axis. (1985) (9)
- A randomized trial of induction doses of interferon alone or in combination with ribavirin or ribavirin plus amantadine for treatment of nonresponder patients with chronic hepatitis C (2007) (8)
- Efficacy and safety of γ-hydroxybutyrate in treating alcohol withdrawal syndrome in an alcohol-dependent inpatient with decompensated liver cirrhosis: a case report. (2011) (8)
- MULTICENTRIC STUDY EVALUATING 4-HYDROXYBUTYRIC ACID SODIUM SALT IN THE MEDIUM-TERM TREATMENT OF 179 ALCOHOL DEPENDENT SUBJECTS (2005) (8)
- Predicting the development of hepatocellular cancer in hepatitis B carriers (2007) (8)
- AISF-SIMTI position paper: the appropriate use of albumin in patients with liver cirrhosis. (2016) (8)
- New infection with heterotypic hepatitis C virus in a patient with long-term hepatitis C virus eradication. (2001) (8)
- Hepatitis C virus reinfection after liver transplantation: is there a role for direct antiviral agents? (2014) (8)
- Vitamins in the treatment of chronic viral hepatitis (2011) (8)
- Dehydroepiandrosterone sulphate and dementia (1998) (8)
- Prognostic Role of Bacterial and Fungal Infections in Patients With Liver Cirrhosis With and Without Acute-on-Chronic Liver Failure: A Prospective 2-Center Study (2020) (7)
- Autonomic neuropathy in liver cirrhosis: prevalence and association with clinical and laboratory features. (1991) (7)
- "Low T3 syndrome" in cirrhosis: effect of beta-blockade. (1989) (7)
- Effects of the combined treatment with thalidomide, megestrol and interleukine-2 in cirrhotic patients with advanced hepatocellular carcinoma. A pilot study. (2005) (7)
- AISF-SIMTI position paper on the appropriate use of albumin in patients with liver cirrhosis: a 2020 update. (2020) (7)
- Daily profile of circulating C-type natriuretic peptide in pre-ascitic cirrhosis and in normal subjects: Relationship with renal function (2007) (7)
- Impact of Acute-on-Chronic Liver Failure on response to treatment with terlipressin and albumin in patients with type 1 hepatorenal syndrome (2017) (7)
- Terlipressin May Decrease In-Hospital Mortality of Cirrhotic Patients with Acute Gastrointestinal Bleeding and Renal Dysfunction: A Retrospective Multicenter Observational Study (2020) (7)
- 88 EFFECT OF CANNABINOID CB1-RECEPTOR ANTAGONISM ON ASCITIC DECOMPENSATION OF RATS WITH PREASCITIC CIRRHOSIS (2008) (7)
- Interferon-α plus indomethacin combined therapy in HBeAg positive chronic hepatitis B non-responder to a previous IFNα course : results of a pilot study (1996) (7)
- Outcome of hepatocellular carcinoma in human immunodeficiency virus-infected patients. (2013) (7)
- Liver and partial atrium transplantation for chronic Budd‐Chiari syndrome (2007) (7)
- Renal sodium handling in cirrhosis with ascites: mechanisms of impaired natriuretic response to reclining. (1994) (7)
- Effect of Liver Transplantation on Tuftsin Activity and Phagocytic Activity of Neutrophil Granulocytes in Patients with Liver Cirrhosis (2005) (7)
- Acute multifocal cerebral white matter lesions during transfer factor therapy (2000) (7)
- Malignant progression of a small HCC nodule: hypovascular 'early HCC' converted to hypervascular 'small HCC' within six months. (2007) (6)
- Effect of the cannabinoid CB1 receptor antagonist SR141716 in a rat model of liver inflammation (2004) (6)
- Lamivudine (LAM) plus HBIg combination therapy compared to HBIg or notherapy in preventing hepatitis B (HBV) recurrence after livertransplantation (LT) (2000) (6)
- Gamma-hydroxybutyrate as a treatment for alcoholism. (2005) (6)
- PS-083-Serum albumin concentration as guide for long-term albumin treatment in patients with cirrhosis and uncomplicated ascites: Lessons from the ANSWER study (2019) (6)
- Hepatitis C virus infection and lymphoproliferative disorders [letter; comment] (1995) (6)
- Letter: calcineurin inhibitor level reduction during treatment with sofosbuvir in liver transplanted patients (2014) (6)
- Cholesterol lowering in patients with CHD and metabolic syndrome (2007) (6)
- Severe hepatic failure occurring with T61 ingestion in an attempted suicide (1993) (6)
- Allocation priority in non-urgent liver transplantation: An overview of proposed scoring systems. (2009) (6)
- Sodium oxybate plus nalmefene for the treatment of alcohol use disorder: A case series (2016) (6)
- [Effect of CDP-choline on senile mental deterioration. Multicenter experience on 237 cases]. (1990) (6)
- Albumin: Indications in chronic liver disease (2020) (6)
- Tenofovir-induced Fanconi syndrome in a patient with chronic hepatitis B monoinfection. (2016) (6)
- Hepatic artery stenosis in liver transplanted patients treated with pegylated interferon alpha-2b and ribavirin. (2004) (6)
- Reoxygenation Injury in Isolated Rat Hepatocytes (1996) (6)
- Sustained and focused hepatitis B virus nucleocapsid–specific T‐cell immunity in liver transplant recipients compared to individuals with chronic and self‐limited hepatitis B virus infection (2008) (6)
- Platelet and blood clotting activation after endoscopic sclerotherapy of oesophageal varices in liver cirrhosis. (1986) (6)
- Hyperammonemic, ammonia-independent coma in experimental acute liver failure induced in the pig. (1981) (6)
- High dose of interferonα (IFN) plus ribavirin (RIBA) for 6 or 12 months in non responder (NR) patients with chronic hepatitis C (CHC): Results of a randomized trial (2000) (6)
- Kinetics of intravenous metoclopramide in patients with hepatic cirrhosis (2004) (6)
- Indomethacin increases 2′,5′-oligoadenylate synthetase release by cultured liver tissue of patients with HCV chronic active hepatitis (1994) (6)
- Hepatitis C virus recurrence after liver transplantation: a 10-year evaluation. (2015) (6)
- Cryoglobulinemia in elderly patients with HCV-related chronic hepatitis. (2010) (6)
- Different mechanisms of "in vitro' lymphocytotoxicity against isolated rabbit hepatocytes during the course of acute viral hepatitis. (1981) (5)
- Immunological modifications during treatment with thymosin α1 plus antiviral therapy in chronic hepatitis C (2010) (5)
- Hepatorenal syndrome and ascites--questions and answers. (1999) (5)
- Use of alcohol during the treatment of alcohol dependence with gamma-hydroxybutyric acid: risk of severe events are avoided by the dose fractioning of the drug. (2007) (5)
- Long-term use of human albumin for the treatment of ascites in patients with hepatic cirrhosis: The interim analysis of the ANSWER study (2015) (5)
- The nutritional status modulates preservation-reperfusion injury in rat fatty liver. (2005) (5)
- The renin-angiotensin-aldosterone system in human hepatic cirrhosis. (1986) (5)
- Bacterial infections in patients with liver cirrhosis (2011) (5)
- [The unifying hypothesis on the regulation of body fluid volume. Physiology and pathophysiology of fluid homeostasis, with particular regard to cardiac decompensation and hepatic cirrhosis]. (2005) (5)
- Direct Antiviral Agents for the Treatment of Hcv Reinfection after Liver (2013) (4)
- Telangiectasia as a Presenting Sign of Graves’ Disease (2008) (4)
- Treatment of alcoholic fatty liver: is the metabolic effect of metadoxine the only reason for improved liver function? (1999) (4)
- Early and late changes in fasting and absorptive plasma amino acids and ammonia after distal splenorenal shunt in cirrhosis (1994) (4)
- Ischemia-reperfusion injury in a diet-induced rat fatty liver. (1998) (4)
- Hyperglycemia at admission, comorbidities, and in-hospital mortality in elderly patients hospitalized in internal medicine wards: data from the RePoSI Registry (2021) (4)
- Acute-on Chronic Liver Failure (ACLF): A distinct clinical syndrome (2012) (4)
- Corrigendum to “Diagnosis and management of acute kidney injury in patients with cirrhosis: Revised consensus recommendations of the International Club of Ascites” [J Hepatol 2015;62:968–974] (2015) (4)
- Renal sodium retention in pre-ascitic cirrhosis: the more we know about the puzzle, the more it becomes intricate. (2010) (4)
- Sodium oxybate to treat alcohol dependence: 20 years of clinical experience (2013) (4)
- Correction and Prevention of Hyponatremia in Patients With Cirrhosis and Ascites: Post Hoc Analysis of the ANSWER Study Database (2022) (4)
- Acute gastrointestinal bleeding prolongs QT interval in cirrhosis (2008) (4)
- Mortality risk in a cohort of Italian alcoholic individuals treated for alcohol dependence (2017) (4)
- Treatment of alcohol dependence with gamma hydroxybutyric acid (2007) (4)
- Metoclopramide administration in advanced liver disease. (1986) (4)
- [Chronic hepatitis B. Recent advances in diagnosis and treatment]. (2002) (4)
- Protective effect of portal vein arterialization in acute liver failure induced by hepatectomy in normal and fatty liver rat. (2006) (4)
- Distal splenorenal shunt and insulin secretion, plasma glucagon, and glucose homeostasis in cirrhosis. (1993) (4)
- Liver Cirrhosis in a Patient with Sickle Cell Trait (Hb Sβ+ Thalassemia) without Other Known Causes of Hepatic Disease (2009) (3)
- O74 URINARY NEUTROPHIL GELATINASE-ASSOCIATED LIPOCALIN (NGAL) IS A STRONG PREDICTOR OF SHORT-TERM OUTCOME IN PATIENTS WITH ACUTE DECOMPENSATION OF CIRRHOSIS. RELATIONSHIP WITH ACUTE-ON-CHRONIC LIVER FAILURE (ACLF) (2014) (3)
- Genetic variability of hepatitis C virus in HBV/HCV co-infection and HCV single-infection (2005) (3)
- T-47 High prevalence of occult hepatitis C virus infection in non alcholic steatohepatitis and cryptogenetic liver diseases (2011) (3)
- IFN plus ribavirin and amantadine for IFN-insensitive patients with chronic hepatitis C: Results of a multicenter, randomized, controlled trial (2003) (3)
- Prospective screening for hepatocellular carcinoma: a debated issue. (1995) (3)
- Prevention of Cirrhosis Complications: Looking for Potential Disease Modifying Agents (2021) (3)
- Ketoprofen, peginterferon 2a and ribavirin for genotype 1 chronic hepatitis C: a phase II study. (2009) (3)
- OC-29 Terlipressin and albumin vs midodrine plus octreotide and albumin in the treatment of hepatorenal syndrome in patients with cirrhosis: results of a controlled clinical trial by A.I.S.F. (2012) (3)
- Cirrhotic cardiomyopathy (2013) (3)
- Familial cluster of hepatitis C virus type 1. (1994) (3)
- Is ceftriaxone better than norfloxacin for prophylaxis of infection in patients with advanced cirrhosis and hemorrhage? (2007) (3)
- Polymorphism rtQ215H in primary resistance to adefovir dipivoxil in hepatitis B virus infection: a case report (2009) (3)
- Increase of ribavirin dose improves sustained virological response in HCV-genotype 1 patients with a partial response to peg-interferon and ribavirin. (2014) (3)
- P508 VALIDATION OF THE CLIF-CONSORTIUM (CLIF-C) SCORE TO PREDICT MORTALITY OF PATIENTS WITH ACUTE-ON-CHRONIC LIVER FAILURE (ACLF) IN AN EXTERNAL COHORT AND FOR SEQUENTIAL MEASUREMENTS (2014) (3)
- Impact of Acute-on-Chronic Liver Failure (ACLF) on response to treatment with terlipressin and albumin in patients with type 1 hepatorenal syndrome (2017) (3)
- Hyperdynamic circulation in cirrhosis: physiology or pathophysiology? (1993) (3)
- Duodenal histology in patients with celiac disease after a gluten-free diet. (2004) (3)
- Focal nodular hyperplasia after busulfan treatment. (2005) (3)
- Correction to 'Blood metabolomics uncovers inflammation-associated mitochondrial dysfunction as a potential mechanism underlying ACLF' [J Hepatol 2020 (72) 688-701]. (2020) (3)
- Hemodynamic and renal effects of ascites apheresis and reinfusion in patients with cirrhosis (1991) (3)
- Alopecia universalis after discontinuation of pegylated interferon and ribavirin combination therapy for hepatitis C: a case report. (2014) (3)
- Transjugular intrahepatic splenosystemic shunt in a patient with portal vein thrombosis. (2001) (3)
- Corrigendum to 'Towards a new definition of decompensated cirrhosis' [J Hepatol 76 (2022) 202-207]. (2022) (3)
- Treatment of alcohol-use disorders (2009) (2)
- Erratum to “The CLIF Consortium Acute Decompensation score (CLIF-C ADs) for prognosis of hospitalised cirrhotic patients without acute-on-chronic liver failure” [J Hepatol 2015;62:831–840] (2015) (2)
- Alcohol-Related Liver Disease in the Covid-19 Era: Position Paper of the Italian Society on Alcohol (SIA) (2021) (2)
- 714 LIVER STIFFNESS VALUES IN HEALTHY SUBJECTS WITHOUT EVIDENCE OF LIVER DISEASE PERFORMED IN A LARGE COMMUNITY-BASED POPULATION (2013) (2)
- 1414 THE CLIF-CONSORTIUM SCORE PREDICTS MORTALITY MORE ACCURATELY THAN THE MELD AND MELD-SODIUM SCORES IN PATIENTS HOSPITALIZED WITH DECOMPENSATED CIRRHOSIS WITH AND WITHOUT ACUTE-ON-CHRONIC-LIVER FAILURE (ACLF). (2013) (2)
- Nutritional status and dementia in oldest-old women (1998) (2)
- GABAergic medications for treating alcohol dependence. (2007) (2)
- Lymphocytotoxicity in acute and chronic alcoholic liver disease: "in vitro" study on effector cells. (1979) (2)
- Mechanism of compensation in pre-ascitic cirrhosis (1990) (2)
- Reply to: "Prophylaxis of spontaneous bacterial peritonitis: is there still room for quinolones?" (2019) (2)
- Methionine breath test to assess mitochondrial liver function after orthotopic liver transplantation (2001) (2)
- Heart failure and chronic kidney disease in a registry of internal medicine wards (2014) (2)
- Effects of somatostatin on plasma ammonia and amino acid profile during fasting and after protein feeding in cirrhotic patients. (1986) (2)
- Effective albumin concentration and albumin function improve after long-term albumin therapy in patients with decompensated cirrhosis (2020) (2)
- Ocular naevus and hyperaemia with dilation of the conjunctival vessels: an early manifestation of Crohn's disease? (1997) (2)
- CD133+ Pluripotent Stem Cells for the Treatment of Chronic Liver Failure. (2010) (2)
- The residual native albumin predicts albumin dysfunction and outcomes in hospitalized cirrhotic patients with acute decompensation or acute-on-chronic liver failure (2019) (2)
- 255 A CASE–CONTROL STUDY EVALUATING THE EFFICACY OF ANTIVIRAL THERAPY AS SECONDARY PROPHYLAXIS OF HEPATOCELLULAR CARCINOMA (HCC) RECURRENCE AFTER CURATIVE TREATMENT IN SUBJECTS WITH HCV-RELATED CIRRHOSIS (2013) (2)
- Occult colon cancer in a patient with an unexplained episode of pulmonary embolism. (2000) (2)
- Role of gluconeogenesis from amino acids in determining fasting and absorptive levels of plasma ammonia in cirrhosis. (1988) (2)
- [Natural course and physiopathology of ascites in the cirrhotic patient]. (1996) (2)
- 603 A MULTICENTER ITALIAN CROSS-SECTIONAL STUDY IN ELDERLY PATIENTS WITH HEPATITIS C VIRUS (HCV) INFECTION (2009) (2)
- The pharmacology and activity of non-steroidal anti-inflammatory drugs (NSAIDs): a review of their use as an adjuvant treatment in patients with HBV and HCV chronic hepatitis (2011) (1)
- Effect of indomethacin (INDO) on antiviral and immune response of peripheral blood mononuclear cells (PBMC8) from patients with chronic hepatitis B virus (HBV) infection (1997) (1)
- QT interval corrected for heart rate is not associated with mortality in patients with cirrhosis and ascites (2019) (1)
- Gluconeogenesis from nitrogen precursors and hyperammonemia of cirrhosis: Is there a cause‐effect relationship? (1989) (1)
- 341 PREVALENCE OF TRANSAMINASE ABNORMALITIES IN GENERAL POPULATION IN XXI CENTURY: THE BAGNACAVALLO STUDY (2010) (1)
- Cirrhosis with ascites: A heterogeneous population (1987) (1)
- High plasma levels of atrial natriuteric peptide (ANP) in pre-ascitic cirrhosis: Evidence of renal hyposensitivity to the peptide (1995) (1)
- P0512 : Liver stiffness measurments using fibroscan after three months of IFN-based antiviral therapy is unlikely to predict viral response in cirrhotic patients (2015) (1)
- Patterns of infections in older patients acutely admitted to medical wards: data from the REPOSI register (2019) (1)
- Inhibition of the cyclooxygenase/lipoxygenase pathways to improve interferon alpha efficacy in chronic hepatitis C: don't lose the tract! (2000) (1)
- Gamma Hydroxybutyric Acid (Ghb): A Valid Pharmacological Opportunity for the Treatment of Alcohol Dependence (2011) (1)
- Reply (2014) (1)
- CB1 receptor antagonist SR141716 delays ascitic decompensation in a rat model of liver cirrhosis (2007) (1)
- Liver, Pancreas and Biliary Tract Effects of granulocyte colony stimulating-factor in a rat model of acute liver injury (2007) (1)
- Proximal tubular damage in cirrhosis. (1982) (1)
- Supernormal hemodynamic response to recumbency in cirrhosis without ascites (1989) (1)
- Reply: To PMID 22095893. (2014) (1)
- Continuous infusion of beta-lactam antibiotics in cirrhotic patients with bloodstream infection: results from a prospective multicentre observational study (2018) (1)
- Thelio-and propriolymphocytes count in normal subjects and in primary and secondary enteropathy. (1978) (1)
- Investigation into the use of alcohol at thermal spas: can a spa represent a place for primary prevention? (1998) (1)
- Portal vein arterialization increases liver regeneration in acute liver failure induced by extended hepatectomy or toxin administration in the rat (2005) (1)
- Impaired tufsin activity in cirrhosis. Relationship with splenic function and clinical outcome (2001) (1)
- Diagnosis and management of acute kidney injury in patients with cirrhosis : Revised consensus recommendations of the International Club of Ascites q (2015) (1)
- Hepatitis C virus (HCV) infection in elderly patients: A multicenter Italian cross-sectional study (2009) (1)
- Ghrelin in alcohol-dependent patients and correlation with nutritional status and craving (2006) (1)
- Oxidative stress contributes to the reduced tolerance of fatty livers to reperfusion injury (1998) (1)
- 242 Natural history of untreated hepatocellular carcinoma (HCC) on cirrhosis: Survival analysis and prognostic factors in 559 patients (2006) (1)
- Ischemia modified albumin (IMA) for the diagnosis of bacterial infection in hospitalized patients with cirrhosis (2014) (1)
- Pharmacokinetics of metoclopramide after single oral dose administration in cirrhosis (1991) (1)
- 316 ACUTE GASTROINTESTINAL BLEEDING PROLONGS QT INTERVAL IN CIRRHOSIS (2008) (1)
- Dorsal acoustic windows may ameliorate liver ultrasound in patients with chronic liver disease and meteorism/obesity/ascites (2013) (1)
- Nutritional status affects the sensitivity to anoxia/reoxygenation in hepatocytes. (1994) (1)
- 1277 GENDER AND LIFE-STYLE INFLUENCES SERUM GAMMA-GLUTAMYLTRANSFERASE LEVELS IN THE GENERAL POPULATION: TIME TO REDIFINE NORMAL LEVELS (2012) (1)
- 489 Pegylated interferon plus ribavirin for the treatment of recurrent HCV infection after liver transplantation (2004) (1)
- 153 THE EFFICACY OF ISCHEMIC PRECONDITIONING IN PROTECTING HUMAN TRANSPLANTED LIVER FROM ISCHEMIA/REPERFUSION INJURY IS ASSOCIATED TO THE ACTIVATION OF PHOSPHOINOSITIDE-3KINASE (2009) (1)
- The heart and other organs Interactions of the heart and the liver (2013) (1)
- Renal function and effective β-blockade in cirrhosis with ascites (1989) (1)
- 739 CIRCULATING AND HEPATIC ENDOCANNABINOIDS AND ENDOCANNABINOID-RELATED MOLECULES IN PATIENTS WITH LIVER CIRRHOSIS (2009) (1)
- Semiannual versus annual surveillance of cirrhotic patients for early diagnosis of hepatocellular carcinoma: Is there a winner? (2009) (1)
- 780 OUTCOME OF HEPATOCELLULAR CARCINOMA IN HIV- INFECTED PATIENTS WITH CHRONIC LIVER DISEASE: A COMPARISON WITH HIV NEGATIVE CONTROLS (2009) (1)
- Alcohol Use in Patients with Chronic Liver Disease. (2018) (1)
- A Randomized Controlled Trial of Thymosin-a1 Versus Interferon Alfa Treatment in Patients With Hepatitis B e Antigen Antibody– and Hepatitis B Virus DNA–Positive Chronic Hepatitis B (1998) (1)
- Outcome of patients with HBeAG negative hepatitis B awaiting liver transplantation (OLT) treated with lamivudine (2001) (1)
- 408 CD133+ STEM CELLS FOR THE TREATMENT OF END STAGE LIVER DISEASE (2012) (1)
- 170 Muscle atrophy in advanced cirrhosis: A neglected factor in the evaluation of regional hemodynamics (2006) (1)
- Interaction Between Non Steroidal Antiinflammatory Drugs and Interferon-α System: Mechanisms and Basis for the Clinical Use in the Treatment of Chronic Viral Hepatitis. (1996) (1)
- Bacterial infections with and without acute-on-chronic liver failure in patients with cirrhosis and acute decompensation: Risk factors and outcome (2018) (1)
- 120 FUNCTIONAL T CELL RESTORATION INDUCED BY PD-1/PD-L1 BLOCKADE IN CHRONIC HEPATITIS B AND C IS IMPROVED BY SIMULTANEOUS MODULATION OF THE CO-STIMULATORY CD137/CD137L PATHWAY (2009) (1)
- [Effects of administration of arginine thiazolidinecarboxylate in liver pathology of various origins. Results of a multicenter study]. (1982) (1)
- Outcome of bacterial infections complicated or not by acute-on-chronic liver failure in patients with cirrhosis admitted to hospital for acute decompensation (2018) (1)
- Clinical and prognostic relevance of albumin dimers in patients with cirrhosis: A novel identified structural alteration of the molecule (2014) (1)
- Transient coagulation abnormalities following endoscopic sclerosis of esophageal varices. (1983) (1)
- Original ContributionsNatural history of cirrhotic patients with small esophageal varices: a prospective study (2000) (1)
- Tenofovir-induced Fanconi syndrome in a patient with chronic hepatitis B monoinfection. (2016) (1)
- Reply (2019) (1)
- Community acquired pneumonia in the emergency department: Comparison of clinical indication to in-hospital treatment and severity scales predicting mortality (2012) (1)
- Medications for alcohol use disorders. (2014) (1)
- 960 HEPATOCELLULAR CARCINOMA (HCC) IN HCV-RELATED CIRRHOSIS: A 20-YEARS SURVEY BY ITA.LI.CA (2011) (0)
- 481 SHOULD HBsAg-POSITIVE GRAFTS CONSIDERED MARGINAL FOR ORTHOTOPIC LIVER TRANSPLANTATION? SINGLE CENTER EXPERIENCE (2009) (0)
- Treatment type is an independent prognostic factor for patients with intermediate stage hepatocellular carcinoma (2014) (0)
- [Treatment of portal hypertension. Indications for and clinical evaluation of portal shunt]. (1978) (0)
- Atherosclerosis (ATH) of the sovraortic district in liver cirrhosis (LC) (2001) (0)
- Prevalence of a 660 amino acid substitution in the PePHD region of HCV-E2 protein in hepatocellular carcinoma (2002) (0)
- [147] DE NOVO AUTOIMMUNE HEPATITIS FOLLOWING LIVER TRANSPLANTATION IN ADULTS: WHAT LIES BEHIND (2007) (0)
- Subject Index, Vol 31, 1985 (1985) (0)
- Recent advances in clinical practice SEPSIS IN CIRRHOSIS : REPORT ON THE 7 TH MEETING OF THE INTERNATIONAL ASCITES CLUB (2005) (0)
- Randomized, controlled pilot trial of interferonα (IFN) with or without thymosinα1 (TA1) in naive chronic hepatitis C (CHC) (2000) (0)
- Effective albumin concentration and albumin function improve after long-term albumin treatment in patients with decompensated cirrhosis (2020) (0)
- HEPATITIS C VIRUS INFECTION AND LYMPHOPROLIFERATIVE DISORDERS. AUTHORS' REPLY (1995) (0)
- Vitamin E as therapy for children with E antigen positive chronic hepatitis B: Results of a randomized controlled trial (2014) (0)
- Relationship between oxidative stress and autonomic neuropathy in liver cirrhosis (1998) (0)
- Predictors of nosocomial acute-on-chronic liver failure for the risk stratification of patients with cirrhosis admitted to hospital with acute decompensation (2019) (0)
- F-44 Prevalence and aetiology of transaminases abnormalities in the general population of a small Italian town: the Bagnacavallo study (2012) (0)
- Reinfusion of highly purified CD133+ stem cells in patients with End-Stage Liver Disease (ESLD): Final results of a phase I clinical trial (2014) (0)
- Carman, W F see Jazayeri, M. Carnot, F see Lebray, P. Caronia, S, McGarvey, M J, Goldin, R D &. Foster, G R. Negative correlation between intrahepatic expression of hepatitis C antigens and apoptosis despite high-level expression of Fas ... (2004) (0)
- Interferon and hepatocellular carcinoma. (1996) (0)
- Clustering of CD8 T cell reponses against the HBV core and surface proteins within different HLA alleles: Immunodominance analisys in patients with diverse genetic background (2007) (0)
- AUTONOMIC NEUROPATHY IN ADVANCED LIVER DISEASE. AUTHORS' REPLY (1996) (0)
- Relationship between autonomic neuropathy and hyperdynamic circulation in cirrhosis (1998) (0)
- T-36 Antiviral therapy as secondary prophylaxis of hepatocellular carcinoma (HCC) recurrence in HCV-related cirrhosis: a case-control study (2013) (0)
- Natremia and Child-Turcotte-Pugh (CTP) score may improve the selection of candidates for liver transplantation (LT) with low model for end-stage liver disease score (MELD) (2009) (0)
- Methionine breath test to assess mithocondrial liver function after orthotopic liver transplantation (2001) (0)
- Antibodies against pegylated interferon-alpha affect response to treatment in patients with chronic hepatitis C. (2012) (0)
- Faculty Opinions recommendation of Rifaximin has no effect on hemodynamics in decompensated cirrhosis: A randomized, double-blind, placebo-controlled trial. (2016) (0)
- F-27 Endocannabinoids in advanced cirrhosis: have we picked the right one? (2012) (0)
- Response to: An In-depth Psychosocial and Biochemical Evaluation in Transplant Recipients for Alcoholic Liver Disease Should Be Planned (2010) (0)
- Eosinophilic gastroenteritis. Comments on 4 cases. (1979) (0)
- Outcome and prognostic factors of untreated hepatocellular carcinoma (HCC) on cirrhosis: Survival analysis of 559 patients (2006) (0)
- Different efficacy of alcohol education tools among trainee nurses. (1999) (0)
- Metoclopramide-induced changes in plasma aldosterone "in vivo" are independent from renin-angiotensin system activity. (1988) (0)
- P0135 : Impact of vasopressin AVP1A receptor gene polymorphisms on mortality and renal failure in patients with acute decompensation of chronic liver disease (2015) (0)
- 667 TERLIPRESSIN AND ALBUMIN VS MIDODRINE PLUS OCTREOTIDE AND ALBUMIN IN THE TREATMENT OF HRS IN PATIENTS WITH CIRRHOSIS: RESULTS OF A CONTROLLED CLINICAL TRIAL BY AISF (2012) (0)
- T-49 Increased survival after sustained virological response in liver transplanted patients with HCV recurrence: Taking up a challenge for the hepatologist (2011) (0)
- 19 HBsAg SERUM LEVELS NEGATIVELY AFFECT HBV SPECIFIC IMMUNE RESPONSE (2010) (0)
- T.N.40 OCCULT HEPATITIS B VIRUS INFECTION IN PATIENTS WITH NON ALCOHOLIC STEATOHEPATITIS (NASH) (2010) (0)
- 219 IDENTIFICATION OF CANCER STEM CELLS IN HUMAN HEPATOCELLULAR AND CHOLANGIOCELLULAR CARCINOMA (2011) (0)
- F-46 HBx-specific immune response in hepatitis B patients with different stage of disease (2011) (0)
- Daily profile of plasma concentrations of endothelin-1 and endothelin-3 in pre-ascitic cirrhosis (1995) (0)
- Current Treatment Strategies: Diuretics (2011) (0)
- Ultrastructural aspects of the liver in cases of constitutional non haemolytic hyperbilirubinemia before and after treatment with barbiturates. Morphological aspects of enzymatic induction. (1972) (0)
- 368 THE FATTY LIVER IN NON OBESE CITIZEN: PRELIMINARY RESULTS FROM A LARGE OSSERVATIONAL STUDY (BAGNACAVALLO STUDY) (2010) (0)
- Prophylaxis and treatment of hepatits B virus infection after liver transplantation (2003) (0)
- Mitochondrial liver function assessment by methionine breath test after orthotopic liver transplantation (2001) (0)
- Gender influence on cold preservation-reoxygenation injury in rat liver (1998) (0)
- Endocannabinoids and liver cirrhosis: The endocannabinoid-related molecule oleoyl-ethanolamine (OEA) correlates with clinical complications and 1-year survival (2014) (0)
- Contents, Vol 31, 1985 (1985) (0)
- Liver regeneration increased by portal vein arterialization in two acute liver failure models in the rat. (2006) (0)
- OC-12 Pegylated interferon-alpha potently augments NK cell antiviral effector function in chronic hepatitis B (2011) (0)
- [Physiopathology and therapy of the ascites in liver cirrhosis]. (1982) (0)
- F.N.49 A MODIFIED CHILD–TURCOTTE–PUGH (CTP) FOR SELECTION OF CANDIDATES TO LIVER TRANSPLANTATION (LT) WITH LOW MODEL FOR END-STAGE LIVER DISEASE SCORE (MELD) (2010) (0)
- Faculty of 1000 evaluation for Survival of patients with cirrhosis and acute peptic ulcer bleeding compared with variceal bleeding using current first-line therapies. (2018) (0)
- Rapid suppression of alcohol withdrawal sindrome by administration of baclofen (2002) (0)
- HBV/HCV coinfection: viral genomic profile of dominant virus (2002) (0)
- Liver, Pancreas and Biliary Tract Pegylated interferon plus ribavirin for recurrent Hepatitis C infection after liver transplantation in na¨ õve and non-responder patients on a stable immunosuppressive regimen (2006) (0)
- 580 POST-TRANSCRIPTIONAL CHANGES OF SERUM ALBUMIN ARE ASSOCIATED WITH CLINICAL FEATURES AND POOR SURVIVAL IN PATIENTS WITH LIVER CIRRHOSIS (2013) (0)
- Combination treatment of post-transplant lymphoproliferative disorders (PTLDs) in liver transplant (OLT) recipients (2002) (0)
- In portal hypertensive cirrhotic patients abdominal porto-systemic collaterals at ultrasound identify a group of patients at high risk of death (2009) (0)
- 155 IMPACT OF THE USE OF ALBUMIN FOR COMPLICATIONS OF CIRRHOSIS ON THE GLOBAL ALBUMIN CONSUMPTION AND PHARMACEUTICAL COSTS IN AN ACADEMIC HOSPITAL (2010) (0)
- T.N.42 THE BAGNACAVALLO FATTY LIVER SCORE MAY PREDICT THE PRESENCE OF METABOLIC SYNDROME IN A GENERAL POPULATION: THE PRELIMINARY RESULTS OF A LARGE OBSERVATIONAL STUDY (BAGNACAVALLO-STUDY) (2010) (0)
- Direct comparison of 5 different treatment strategies for hepatocellular carcinoma (HCC) in cirrhosis: Survival according to disease stage. (2005) (0)
- F.N.42 LIVER STEATOSIS IN NORMAL WEIGHT SUBJECTS: PRELIMINARY RESULTS FROM A LARGE OBSERVATIONAL STUDY (BAGNACAVALLO STUDY) (2010) (0)
- 145 Outcome of liver transplant for alcoholic liver disease (2004) (0)
- Atorvastatin and alcohol consumption. (2007) (0)
- [Double-blind polycentric study of the action of S-adenosylmethionine in hepatic cirrhosis]. (1975) (0)
- Factors influencing patients' response to medical treatment of ascites: A randomized clinical trial (1991) (0)
- [Role of hepatocyte necrosis in changes of the serum amino acid pattern in acute hepatic insufficiency. Experimental study]. (1980) (0)
- F-26 Liver stiffness values in healthy subjects without evidence of liver disease performed in an adult community-based population (2013) (0)
- GRANULOCYTE COLONY STIMULATING FACTOR (G-CSF) ADMINISTRATION IN CIRRHOTIC PATIENTS: A PHASE II STUDY EVALUATING TOLERABILITY PROFILE AND MOBILIZATION OF HAEMATOPOIETIC STEM CELLS (HSCS). (2005) (0)
- 748 EFFECT OF B3-ADRENOCEPTOR MODULATION ON PORTAL PRESSURE IN RATS WITH COMPENSATED CIRRHOSIS (2009) (0)
- Chronic ethanol administration affects oxydative stress by ischemia/reperfusion in rat liver (1998) (0)
- F-1 Identification of cancer stem cells in human hepatocellular and cholangiocellular carcinoma (2011) (0)
- Liver, Pancreas and Biliary Tract Doxorubicin coupled to lactosaminated albumin: Effects on rats with liver fibrosis and cirrhosis (2006) (0)
- 557 PREVALENCE AND MUTATIONAL PATTERN OF OCCULT HEPATITIS B VIRUS ISOLATED FROM LIVER TISSUE OF HIV INFECTED PATIENTS (2008) (0)
- in patients with cirrhosis Optimum use of diuretics in managing ascites (2010) (0)
- Helicobacter pylori gastritis with cytotoxin associated protein antibodies (CagA): A computer aided evaluation of imflammatory cell infiltration in the lamina propria, atrophic gastritis and acquired malt (1995) (0)
- Gamma-hydroxy-butirric acid plus naltrexone in the treatment of alcoholics resistent to monotheraphy. (2004) (0)
- T-48 Increasing ribavirin doses improves the sustained virological response in HCV patients not responding to pegylated interferon and ribavirin (2011) (0)
- A novel experimental model of decompensated liver cirrhosis induced by CCl4 inhalation in mice (2008) (0)
- 148 LIVER TRANSPLANTATION IN CIRRHOTIC PATIENTS WITH MELD SCORE 18: A NEW PROGNOSTIC MODEL TO PREDICT DROP-OUT FROM THE WAITING LIST (2013) (0)
- Autonomic neuropathy in liver cirrhosis. Prevalence and associated factors (1989) (0)
- [408] IMMUNODOMINANCE ANALYSIS OF HBV-SPECIFIC CELLULAR IMMUNE RESPONSE IN TWO HLA IDENTICAL, VERTICALLY INFECTED SIBLINGS (2007) (0)
- Ultrastructural aspects of endocrine duodenal cells in various physiologic and pathologic states. (1970) (0)
- 10 OP Efficacy of baclofen in reducing craving and maintenance of alcohol abstinence double blind randomised trial with placebo (2002) (0)
- Clinical presentation, treatment and outcome of alcohol- and hepatitis C virus- related hepatocellular carcinoma in the new century: comparison before and after adjustment with propensity score analysis (2015) (0)
- De novo autoimmune hepatitis following liver transplantation in adults: A polymorphic disease (2006) (0)
- Dysregulation of microRNA expression in PBMCs from patients with HCV-related malignancies (2014) (0)
- Effects Q1 of Albumin Q2 Treatment Q3 on Systemic and Portal Hemodynamics and Systemic In fl ammation in Patients With Decompensated Cirrhosis (2019) (0)
- F.N.10 PHARMACOLOGICAL ANTAGONISM OF ENDOCANNABINOID CB1 RECEPTOR AMELIORATES LIVER FIBROSIS IN A RAT MODEL OF ADVANCED CIRRHOSIS (2010) (0)
- Hemodynamic and renal eff'ects of ascites apheresb concentration reinfbsion in advanced cirrhosis (1995) (0)
- 619 NEGATIVE CORRELATION BETWEEN HBSAG SERUM LEVELS AND HBV-SPECIFIC IMMUNE RESPONSES (2010) (0)
- Development of Different Psychiatric Manifestations during Antiviral Therapy for Chronic Hepatitis C (2014) (0)
- Faculty Opinions recommendation of Beta adrenergic blockade and decompensated cirrhosis. (2017) (0)
- Management of malnutrition in patients with cirrhosis requires a personalized educational approach (2016) (0)
- Supernormal bed rest-induceo natriuresis in cirrhotic patents without ascites (1989) (0)
- QT interval in patients with cirrhosis: failure of Bazett’s correction and identification of a disease-specific formula. (2007) (0)
- New and Old Drugs to Treat Alcohol Use Disorders (2014) (0)
- Reply (to LTE HEP‐19‐0174) (2019) (0)
- Pathophysiology of Cirrhotic Ascites (1987) (0)
- Faculty Opinions recommendation of Identification of optimal therapeutic window for steroid use in severe alcohol-associated hepatitis: A worldwide study. (2021) (0)
- P519 CD133+ HEMATOPOIETIC STEM CELLS REINFUSION IN END-STAGE LIVER DISEASE (ESLD): FINAL RESULTS OF A PHASE I CLINICAL TRIAL (2014) (0)
- 1126 THE STAGE OF DISEASE INFLUENCES THE HBX-SPECIFIC IMMUNE RESPONSE IN PATIENTS WITH CHRONIC HEPATITIS B INFECTION: A CROSS SECTIONAL ANALYSIS (2011) (0)
- Guidelines for the use of human albumin in S. Orsola-Malpighi University Hospital: A 3-year experience (2007) (0)
- Hyperfibrinolysis but not hypercoagulability after a new ascites-apheresis procedure in liver cirrhosis patients with refractory ascites (1996) (0)
- [Morpho-functional study of the liver after treatment with gentamicin in cases of biliary tract infections]. (1974) (0)
- Polymorphismus in the Interleukin (IL)-1 Gene Cluster Influence the Inflammatory Burden in Patients with Decompensated Cirrhosis and Acute-On-Chronic Liver Failure (2016) (0)
- Efficacy of baclofen in reducing alcohol craving and intake: a double blind randomized controlled trial (2002) (0)
- One year lamivudine (LAM) treatment of “e minus” chronic hepatitis B (CHB): Biochemical, virological and histological results (2000) (0)
- Successfull portal vein arterialization for fulminant hepatic failure (2004) (0)
- Inadequate Nutrition in Patients with Cirrhosis: The Need of a Personalized Educational Program (2016) (0)
- In vitro Lymphocytotoxicity in Intrahepatic Cholestasis1 (1979) (0)
- Visualization of post-ischemic free radicals formation in livers isolated from rats chronically exposed to ethanol (1998) (0)
- Survival in untreated and treated patients with HCC on cirrhosis according to the stage and treatment procedure: analysis of 1187 cases. (2004) (0)
- OC-18 Liver transplantation in cirrhotic patients with MELD score <18: a new model to predict drop-out from the waiting list (2013) (0)
- Fatty degeneration exacerbates mitochondrial dysfunction in the rat liver exposed to preservation-reperfusion injury (2002) (0)
- 9 DIFFERENTIAL EFFECTS OF PEGYLATED INTERFERON ALPHA THERAPY ON INNATE AND ADAPTIVE IMMUNE RESPONSES IN CHRONIC HEPATITIS B (2010) (0)
- INTRAFAMILIAL SPREADING OF HCV INFECTION: ANALYSIS OF HCV GENOTYPES (1995) (0)
- 1 P Quantitative evaluation of liver function by methionine and aminopyrine breath tests in the early stages of liver transplantation (2002) (0)
- The kynurenine pathway in cirrhosis. Relationship with the development of acute decompensation and acute-on-chronic liver failure, clinical course and mortality (2018) (0)
- 702 HEPATITIS B SURFACE ANTIGEN SERUM LEVELS AND SPECIFIC T CELLS RESPONSE IMPROVE THE MONITORING OF NUCLEOSIDE ANALOGUES TREATMENT IN HBEAG-NEGATIVE CHRONIC HEPATITIS B (2008) (0)
- T.N.17 DIFFERENTIAL EFFECTS OF PEGYLATED INTERFERON ALPHA THERAPY ON INNATE AND ADAPTIVE IMMUNE RESPONSES IN CHRONIC HEPATITIS B (2010) (0)
- Practice Guidelines EASL clinical practice guidelines on the management of ascites , spontaneous bacterial peritonitis , and hepatorenal syndrome in cirrhosis European Association for the Study of the Liver 1 (2010) (0)
- 394 DIFFERENTIAL DIAGNOSIS BETWEEN FOCAL NODULAR HYPERPLASIA AND HEPATOCELLULAR ADENOMA: POTENTIAL ROLE OF DOUBLE TRACER PET WITH 11C-ACETATE AND 18F-FDG (2008) (0)
- 301 Pegylated Interferon-Alpha Potently Augments Nk Cell Antiviral Effector Function (2011) (0)
- 34 Detectable HBV-specific T cell responses in liver transplant recipients: A comparison to chronic hepatitis B (2006) (0)
- P1088 VITAMIN E AS THERAPY FOR CHILDREN WITH E ANTIGEN POSITIVE CHRONIC HEPATITIS B: RESULTS OF A RANDOMIZED CONTROLLED TRIAL (2014) (0)
- Evidence-Based Decision for Pharmacological Management of Alcoholic Liver Disease and Alcohol Dependence (2010) (0)
- Questions in the design of ANSWER – Authors' reply (2018) (0)
- Faculty Opinions recommendation of Fat-free muscle mass in magnetic resonance imaging predicts acute-on-chronic liver failure and survival in decompensated cirrhosis. (2018) (0)
- 811 A MODIFIED CHILD-TURCOTTE-PUGH (CTP) FOR SELECTION OF PATIENTS AFFECTED BY CIRRHOSIS CANDIDATES TO LIVER TRANSPLANTATION (LT) WITH LOW MODEL FOR END-STAGE LIVER DISEASE SCORE (MELD) (2010) (0)
- 466 NATREMIA AND CHILD-TURCOTTE-PUGH (CTP) SCORE MAY IMPROVE THE SELECTION OF CANDIDATES FOR LIVER TRANSPLANTATION (LT) WITH LOW MODEL FOR END-STAGE LIVER DISEASE SCORE (MELD) (2009) (0)
- F-39 Alpha-fetoprotein changes as surveillance test for hepatocellular carcinoma: results of a case-control study (2013) (0)
- T-2 The evolving clinical scenario of hepatocellular carcinoma over the last 20 years in Italy (2011) (0)
- FIRST REPORT OF FULMINANT HEPATIC FAILURE TREATED WITH PORTAL VEIN ARTERIALIZATION AVOIDING LIVER TRANSPLANTATION (2004) (0)
- The TLR10 polymorphism rs4129009 is associated to poor 28-day survival in patients with cirrhosis and acute on chronic liver failure precipitated by bacterial infection (2016) (0)
- [227] CONTRAST ENHANCED ULTRASOUND WITH SONOVUE. A NEW TOOL TO DETECT PERITONEAL-PLEURAL COMMUNICATIONS IN CIRRHOTIC PLEURASCITES (2007) (0)
- Surveillance for hepatocellular carcinoma in elderly cirrhotic patients. Effects on cancer staging and patient survival (2002) (0)
- Anti-endothelial cell antibodies in Crohn's disease (1998) (0)
- Surveillance for early diagnosis of hepatocellular carcinoma (HCC): Is it effective in intermediate/advanced cirrhosis? (2007) (0)
- Efficacy of baclofen in reversing alcohol withdrawal syndrome and controlling alcohol craving and consumption in human alcoholics (2002) (0)
- Chemiluminescent real time imaging of oxygen free radicals formation in isolated liver exposed to ischaemia/reperfusion (1996) (0)
- Ultrastructural aspects of the liver in the cholestasis of the pregnancy. (Abstract only) (1976) (0)
- TLR-10 Single Nucleotide Polymorphism is Associated to Poor Short Term Survival in Cirrhotic Patients with Acute on Chronic Liver Failure Precipitated by Bacterial Infections (2016) (0)
- Shock, Microcirculation and Reperfusion Injury II (1999) (0)
- A Pilot Study To Evaluate the Safety, Efficacy and Effects on Liver Function of Granulocyte Colony-Stimulating Factor To Mobilize Hematopoietic Stem Cells in Patients with Liver Cirrhosis. (2005) (0)
- Should HBsAg-positive grafts considered marginal for orthotopic liver transplantation? (2009) (0)
- OC-35 Post-transcriptional changes of serum albumin and its relationship with clinical features and prognosis in cirrhotic patients (2013) (0)
- Study on Factors Affecting the Natriuretic Efficacy of Spironolactone in Cirrhosis with Ascites (1986) (0)
- Mycophenolate mofetil plus low-dose calcineurin inhibitor for renal dysfunction in liver transplant: A 24-month controlled clinical trial (2007) (0)
- O1 ADMINISTRATION OF THE CANNABINOID CB1-RECEPTOR ANTAGONIST PROTECTS AGAINST SEPSIS IN RAT CIRRHOSIS (2012) (0)
- ESTABLISHMENT OF ANIMAL MODEL WITH SIDE EFFECTS INDUCED BY MYCOPHENOLATE MOFETIL AND PHARMACO- HISTOLOGICAL ANALYSIS OF THEM (2006) (0)
- Extending antiviral treatment for 12 months after HCV-RNA clearance is associated with a high response rate in difficult-to-treat HCV patients (2007) (0)
- Use of albumin infusion for cirrhosis-related complications: an international position statement (2023) (0)
- Pancreatic hormones and glucose homeostasis after distal splenorenal shunt (DSRS) in cirrhosis (1991) (0)
- Natriopeptide (ANP)-induced hypernatriuresis in pre-ascitic cirrhotics during prolonged recumbency (1990) (0)
- 1003 THE EVOLVING CLINICAL SCENARIO OF HEPATOCELLULAR CARCINOMA OVER THE LAST 20 YEARS IN ITALY (2011) (0)
- Faculty Opinions recommendation of Infections in patients with cirrhosis increase mortality four-fold and should be used in determining prognosis. (2011) (0)
- Clinico-pathologic features of hepatocellular carcinoma (HCC) in Western Children and Adolescents (1995) (0)
- Mandarin Translations (2012) (0)
- Endoarterial therapy (EAT) in patients with hepatocellular carcinoma (HCC). Comparison between elderly and younger subjects (2000) (0)
- Endocannabinoids and endocannabinoid-related molecules in patients with liver cirrhosis (2009) (0)
- Long-term albumin administration is not futile in patients with cirrhosis and uncomplicated ascites not normalizing serum albumin concentration with treatment (2020) (0)
- Liver and biliary Renal function impairment induced by change in posture in patients with cirrhosis and ascites (2006) (0)
- Human Albumin: An Important Bullet Against Bacterial Infection in Patients with Liver Cirrhosis? (2015) (0)
- [Usefulness of small intestine biopsy in the diagnosis of malabsorption syndromes]. (1974) (0)
- ECHO-COLOUR-DOPPLER CHARACTERIZATION OF CIRRHOTIC PATIENTS RESPONDERS AND NON-RESPONDERS TO NADOLOL AS PRIMARY PROPHYLAXIS. (2005) (0)
- 405 TLR 3 INDUCED EXPRESSION OF RANTES MODULATES THE FUNCTION OF ACTIVATED PRIMARY HEPATIC STELLATE CELLS (2012) (0)
- 34 Anandamide is a powerful and selective vasodilator in the mesenteric resistance arteries of cirrhotic rats (2003) (0)
- BRIEF COMMUNICATION PLATELFT AND BLOOD QMITING ACTIVATION AFTER ENJXSCOPIC SCLEROTHERAPY OF OESOPHAGEAL VARICFS IN LIVER CIRRHOSIS (1986) (0)
- Biochemical and 31P-NMR spectroscopic evaluation of immobilized perifused rat hepatocytes exposed to anoxia: Relation to the nutritional status (1994) (0)
- Diuretic treatment and renin-aldosterone axis in liver cirrhosis. (1984) (0)
- Sequence of NS5A2209–2248 region of hepatitis C virus in hepatocellular carcinoma (2000) (0)
- Faculty Opinions recommendation of Deleterious effects of beta-blockers on survival in patients with cirrhosis and refractory ascites. (2011) (0)
- Transcatheter arterial chemoembolization therapy (TACE) for patients with hepatocellular carcinoma (HCC): a comparative study using a matched untreated cohort (2002) (0)
- Hepatocellular carcinoma (HCC): Topographic study (1991) (0)
- Adverse Reactions to Foods (2000) (0)
- 122 Hematopoietic stem cell mobilization in patients undergoing liver transplant or liver resection (2006) (0)
- Prophylaxis and treatment of hepatis B virus infection after liver transplantation. (2003) (0)
- OC-18 CD133+ stem cells for the treatment of end stage liver disease (2012) (0)
- Potassium kanrenoate decreases the incidence of portal hypertension-related complications in compensated cirrhosis. A double-blind randomized study. (2004) (0)
- [Effect of the pharmacological antagonism of the endocannabinoid receptors on the sodium balance in liver cirrhosis]. (2011) (0)
- Hyperbaric oxygen reduces rat liver preservation injury preserved in a hypotermic machine perfusion (2008) (0)
- 11 OC Rapid suppression alcohol withdrawal syndrome by administration of baclofen (2002) (0)
- HCV GENOTYPES AND INTRAFAMILIAL SPREADING OF HCV INFECTION (1995) (0)
- 237 Long-term beta-blockade shortens QT interval prolongation in patients with liver cirrhosis (2006) (0)
- [The liver and cholelithiasis. Morphofunctional study of the liver in gallbladder calculosis]. (1976) (0)
- A new liver extracorporeal device (LEONARDO) to treat swine with post-resection acute liver failure (2006) (0)
- 569 ENDOCANNABINOIDS AND CIRRHOSIS: HAVE WE PICKED THE RIGHT ONE? (2012) (0)
- Oxidative damage in mitochondria isolated from rat fatty liver exposed to warm ischemia-reperfusion injury (2001) (0)
- 917 DEVELOPMENT OF PSYCHIATRIC SYMPTOMS DURING ANTIVIRAL THERAPY FOR CHRONIC HEPATITIS C: A RETROSPECTIVE STYUDY ON 590 SUBJECTS (2013) (0)
- Effect of β3-adrenoceptor agonist SR58611A on portal pressure of rats with compensated cirrhosis (2009) (0)
- PS-102-Circulating native albumin in patients with cirrhosis admitted to hospital for acute decompensation and acute-on-chronic liver failure: Relation to serum albumin levels, albumin function, and patient outcomes (2019) (0)
- Plasma Cystatin C is a predictor of renal failure, hepatorenal syndrome, ACLF and mortality in patients with acutely decompensated liver cirrhosis (2016) (0)
- Reduction of Fasting and Absorptive Blood Ammonia by Somatostatin Infusion in Patients with Liver Cirrhosis (1984) (0)
- P0185 : Acute-on-Chronic Liver Failure not associated with bacterial infections. Characteristics, prognosis and importance of systemic inflammatory response (2015) (0)
- Mitochondrial injury in rat fatty liver exposed to cold preservation and reperfusion (2001) (0)
- F-28 Gender and life-style influences on serum gamma-glutamyltransferase levels: time to change the normal range in the general population (2012) (0)
- [Hyponatremia in cirrhosis with ascites]. (1990) (0)
- [Catecholamine and renin-angiotensin system in blood pressure control in patients with liver cirrhosis]. (1981) (0)
- P-28RISK OF RE-HOSPITALIZATION IN PATIENTS ATTENDING THE EMERGENCY DEPARTMENT FOR ACUTE ALCOHOL INTOXICATION: AN OBSERVATIONAL RETROSPECTIVE STUDY (2015) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Mauro Bernardi?
Mauro Bernardi is affiliated with the following schools:
